Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Lilly Emphasizes China in Strategic Plan

publication date: Apr 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Eli Lilly and Company will not attempt a large-scale merger similar to the ones currently in the big pharma news; instead, the company says it will continue to implement its diversified drug development model, with a healthy dose of partnerships adding to in-house R&D. One of the goals of the company is to become the fastest growing pharmaceutical company operating in China. More details...

Stock Symbol: (NYSE: LLY)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners